Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-034104

Chief Financial Officer sold 3,900 shares at $28.19 ($109,955)

  • Chief Financial Officer acquired 3,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Viret Jean-Frederic Chief Financial Officer 2016-11-18 Option exercise +3,900 $13.50 $52,650 6,225 D: show line 1 in the form
Viret Jean-Frederic Chief Financial Officer 2016-11-18 Sale −3,900 $28.19 $109,955 2,325 D: show line 2 in the form
Open-market sales · 3,900 sh · avg $28.19 · $109,955

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Viret Jean-Frederic Chief Financial Officer 2016-11-18 Option exercise · Stock Option (right to buy) −3,900 120,948 D: show line 3 in the form
Loading xslF345X03/doc4.xml…